No Prescription |
 |
 | ||
|
Norilet Noroxin |
|
| ||
No Prescription » Prescription Drugs 12 » Norilet Noroxin Norfloxacin is an antibiotic used to treat certain infections caused by bacteria such as gonorrhea prostate and urinary tract infections. Antibiotics will not work for colds flu or other viral infections.Norfloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria.This antibiotic treats only bacterial infections. It will not work for virus infections (e.g. common cold flu). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.How to use Norfloxacin OralTake this medication by mouth usually twice a day at least 1 hour before or 2 hours after a meal or dairy products (e.g. milk yogurt). Take with a full glass of water (8 ounces or 240 milliliters). The dosage is based on your medical condition and response to treatment. Drink plenty of fluids while taking this medication unless your doctor tells you otherwise.Take this medication at least 2 hours before or 2 hours after taking any drugs that contain magnesium aluminum or calcium. Some examples include quinapril certain forms of didanosine (chewable/dispersible buffered tablets or pediatric oral solution) vitamins/minerals and antacids. Follow the same instructions if you take calcium-enriched juice bismuth subsalicylate sucralfate iron and zinc. These medications/products bind with norfloxacin and prevent its full absorption.Antibiotics work best when the amount of medicine in your body is kept at a constant level. It is important not to miss a dose. To help you remember take this medication at the same times every day.Continue to take this medication until the full prescribed amount is finished even if symptoms disappear after a few days. Stopping the medication too early may allow bacteria to continue to grow which may result in a return of the infection.Tell your doctor if your condition persists or worsens.Norfloxacin Oral is used to treat the following:Acute Gonorrhea of the Lower Genital and Urinary Organs Acute Gonorrhea of the Urethra Acute Gonorrhea of the Cervix Urinary Tract Infection Infection of the Prostate Gland caused by E. ColiNorfloxacin Oral may also be used to treat:Inflamed Stomach/Intestines caused by Bacterial Infection Traveler's Diarrhea Treatment to Prevent Traveler's Diarrhea Buy Norilet Noroxin and other Prescription Drugs 12 products online at Medstore. Buy Online at Medstore - Click Here!
About Norilet Noroxin: Product Type: Prescription Drugs 12 Norilet ( Noroxin GENERIC Norfloxacin ) Norilet (Noroxin GENERIC Norfloxacin) Noroxin GENERIC Norfloxacin 400mg Noroxin GENERIC Norfloxacin Norilet
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
